Arkolith/Insider Trading/LXRX/Form 4

Debbane Raymond

DirectorLEXICON PHARMACEUTICALS, INC. (LXRX) · full profile →Form 4 · filed Feb 18, 2026
Net Buying
Open-Market Buys
$353K
Open-Market Sells
$0
Net Open-Market Flow
$353K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Buy(P)134K$1.32$176K1.7M
Feb 17, 2026Buy(P)77K$1.31$101K1.5M
Feb 13, 2026Buy(P)58K$1.31$76K1.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062822-26-000029) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML